Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Neuronal Connettivity Along the Visual Pathways in Patients Affected by Glaucoma Throug Treatment With Citicoline Oral Solution: Multimodal Morpho-funcional Study

NCT05315206 is registered in ClinicalTrials.gov with Fondazione G.B. Bietti, IRCCS as lead sponsor.

NCT NCT05315206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05315206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Neuronal Connettivity Along the Visual Pathways in Patients Affected by Glaucoma Throug Treatment With Citicoline Oral Solution: Multimodal Morpho-funcional Study
Lead sponsor
Fondazione G.B. Bietti, IRCCS
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 25, 2022
Completion date
July 31, 2025
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma